ScTIL / Chineo Medical Technology 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ScTIL / Chineo Medical Technology
NCT05342506: Clinical Study on the Safety, Pharmacokinetics, and Efficacy of ScTIL (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Gynecological Malignancies

Not yet recruiting
2a
30
NA
Toripalimab + ScTIL
Peking Union Medical College Hospital, Chineo Medicine (Beijing) Co., Ltd.
Cervical Cancer, Ovarian Cancer, Malignant Trophoblastic Tumor
02/24
05/24
NCT05499715: A Phase I Clinical Study to Evaluate the Safety, the Tolerability, the Pharmacokinetic Characteristics and the Efficacy of ScTIL Injection (Genetically Modified Tumor Infiltrating Lymphocytes) in the Treatment of Advanced Malignant Solid Tumors

Not yet recruiting
1
48
RoW
ScTIL injection
Chinese Academy of Medical Sciences, Beijing ChineoMedical Technology Co., Ltd
Advanced Tumor of Digestive Tract or Urinary System
05/24
08/24
ChiCTR2100044420: Clinical study on the safety and efficacy of E/S(c)TIL (Gene-modified tumor infiltrating lymphocytes) in the treatment of malignant solid tumors

Recruiting
N/A
60
 
Chemotherapy preconditioning + EcTIL cell ;Chemotherapy preconditioning + ScTIL cell ;Chemotherapy preconditioning + ScTIL cell + B cell booster adjuvant ;Chemotherapy preconditioning + ETIL cell ;Chemotherapy preconditioning + STIL cell ;Chemotherapy preconditioning + STIL cell + B cell booster adjuvant
The First Affiliated Hospital of Zhengzhou University; CHINEO MED (BEIJING) CO., LTD, Beijing ChineoMedical Technology Co., Ltd will provides research funding support and research cells
Malignant solid tumors
 
 

Download Options